GRAFT-IN Launches Operations in Nigeria
On 7.2.2024, Graft-In International and REDDRESS Medical in collaboration with our local distributor – IES Medical and Dr. David Obasi Ukoha from Lone Star Global Consult Ltd group, launched ACTIGRAFT…
FAQ
How does ACTIGRAFT work? A common problem in non-healing wounds is poor blood circulation in the wound area. ACTIGRAFT addresses this by creating a natural blood clot from the patient’s…
Graft-In International Unveils Revolutionary ACTIGRAFT Wound Care Treatment Vietnam, 7.10.2023
Graft-In International, a leader in wound care solutions, unveiled its groundbreaking ACTIGRAFT treatment on October 7, 2023 in a burns and wound conference in Ha-Long, Vietnam. This cutting-edge product promises…
Introducing ActiGraft® – Revolutionary Wound Care Solution
Introducing ActiGraft® - Revolutionary Wound Care Solution ActiGraft®: Medical device for wound management. The ultimate biological wound or replace (not both care and treatment) treatment solution to help patients recover…
GRAFT-IN Launches Operations in Kazakhstan
06/2023 GRAFT-IN, in cooperation with its representative IES Medical, Launches Operations in Kazakhstan and Secures Strategic Partnership with Ministry of Health [Astana, June 7, 2023] – GRAFT-IN, is pleased to…
ACTIGRAFT Shines at Innovative Medical Technologies Conference in Azerbaijan
05/2023 Graft-In International, a leading medical technology company, is thrilled to announce the successful participation of ACTIGRAFT, its flagship product, at the recent Innovative Medical Technologies Conference held in Baku,…
Visit to government oncologic hospital, Tashkent
07/2022 ACTIGRAFT Presentation in the government Oncologic hospital in Tashkent, full conference room with around 50 doctors and surgeons under the hospitality of the hospital’s general manager. Presentation and discussion…
ACTIGRAFT Vs. others
ACTIGRAFTPRP (Platelet-rich plasma)PRF, Growth factors & other blood productsA three-dimensional matrix containing a fibrin net, which forms a stable basis for growth factors and blood vessels, migration of cells, capturing…
Launching in Uzbekistan: MOH approval
06/2022 – Actigraft has received the approval of the Ministry of Health in Uzbekistan. We will start our activities soon, aiming to improving life quality for those suffering from diabetic…